drugset / Trial / NCT01216384
Single Rising Dose (SRD), Multiple Rising Dose (MRD) Study of BI 671800 in Healthy Asian Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of the current study is to investigate the safety and tolerability of BI 671800 HEA in healthy Chinese male volunteers following single oral administration, and healthy Japanese male volunteers following single oral administration and multiple administrations.
Timeline
- Start
- 2010-10
- Primary completion
- 2010-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 671800 | Small molecule | 50 mg | Oral |
| Subject | BI 671800 | Small molecule | 200 mg | Oral |
| Subject | BI 671800 | Small molecule | 400 mg | Oral |